Shanghai Hile Bio-Technology Co.,Ltd.’s Net Profit Rose 29.2% in First Half of 2022

Shanghai Hile Bio-Technology Co.,Ltd. (上海海利生物技术股份有限公司) (603718.SH) reported a net profit of 29.5 million yuan in the first half of 2022, up 29.2% year-on-year.

Meanwhile, the company posted 171 million yuan in revenue, up 1.7% year-on-year.

At the end of the reporting period, it had 1.9 billion yuan in total assets and 923.7 million yuan in total liabilities, with a liability-to-asset ratio of 47.7%.